跳至主要内容
临床试验/NCT02663609
NCT02663609已完成不适用

Retrospective Chart Review Study of Korlym for the Treatment of ACTH Independent Cushing's Syndrome

Corcept Therapeutics0 个研究点目标入组 24 人开始时间: 2015年10月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
24
主要终点
Drug Utilization Patterns as assessed by chart review

研究概览

简要总结

Chart review study to collect patient data from medical charts of patients who have been treated with Korlym® for the treatment of ACTH independent adrenal Cushing's Syndrome.

详细描述

A retrospective, multi-center, chart review study to collect patient data from medical charts of patients who have been treated with Korlym® for the treatment of ACTH independent adrenal Cushing's Syndrome. Treatment with Korlym® will be a minimum 3 months in duration with follow-up of a minimum 3 months. Only sites that have been identified to have patients appropriate for this protocol will be invited to participate.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosed with ACTH independent endogenous Cushing's Syndrome
  • Available adrenal imaging prior to being treated with Korlym®
  • Treated with Korlym® and followed for at least 3 months (follow-up data should be available)

排除标准

  • Diagnosed with adrenocortical carcinoma
  • Participant in any clinical trial(s) during the observational period

结局指标

主要结局

Drug Utilization Patterns as assessed by chart review

时间窗: up to 4 years

The retrospective review would analyze the drug utilization patterns of patients treated with Korlym

次要结局

  • Clinical Outcomes as assessed by chart review(up to 4 years)

研究者

申办方类型
Industry
责任方
Sponsor

相似试验